Indiana Won't Sign Onto $48M Healthpoint FCA Deal

Law360, New York (December 20, 2012, 6:04 PM EST) -- Indiana officials on Wednesday asked a Massachusetts federal judge to reopen a False Claims Act whistleblower suit against Healthpoint Ltd. over improper billing for Xenaderm skin ointment, saying they've been unable to reach terms in a matter the federal government recently settled for $48 million.

Indiana's motion to revive the case, filed two weeks after the federal government announced a deal, says the state hasn't managed to come to a meeting of the minds with Healthpoint, a DFB Pharmaceuticals Inc. subsidiary accused of ripping off Medicare...
To view the full article, register now.